Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.44 |
| ▸ | FABP4 | P15090 | 1/20 | 0.44 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.40 |
| ▸ | CASP6 | P55212 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | NT5E | P21589 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | SNCA | P37840 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18523201 | 0.81 | ALDH1A1 (0.53) | FABP3FABP4FABP5ALDH1A1HSD17B10 | |
| SCHEMBL17417188 | 0.81 | HTT (0.54) | FABP3FABP4FABP5ALDH1A1HSD17B10 | |
| SCHEMBL11400620 | 0.81 | FABP3 (0.58) | FABP3FABP4FABP5ALDH1A1LMNA | |
| SCHEMBL531432 | 0.81 | LMNA (0.47) | FABP3FABP4FABP5ALDH1A1CASP6 | |
| SCHEMBL7978251 | 0.79 | ALDH1A1 (0.52) | FABP3FABP4FABP5ALDH1A1HSD17B10 | |
| SCHEMBL157022 | 0.79 | NT5E (0.44) | FABP3FABP4FABP5ALDH1A1HSD17B10 | |
| SCHEMBL157021 | 0.79 | FABP3 (0.43) | FABP3FABP4FABP5HSD17B10LMNA | |
| SCHEMBL11323822 | 0.79 | FABP3 (0.56) | FABP3FABP4FABP5ALDH1A1LMNA | |
| SCHEMBL6734428 | 0.77 | ALDH1A1 (0.46) | FABP3FABP4FABP5ALDH1A1HSD17B10 | |
| SCHEMBL5290812 | 0.77 | CA1 (0.44) | FABP3FABP4FABP5ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009141627-A1 | TREATING NIEMANN-PICK DISEASE TYPE C AND RELATED DISORDERS BY ELEVATING INTRACELLULAR CALCIUM | ISIS INNOVATION LIMITED (GB) | 2009-11-26 | — | — | WO | disclosed |
| US-20080241090-A1 | Use of Fluorescent Perylene Compounds for the Treatment of Human Hair | WELLA AKTIENGESELLSCHAFT (DE) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080241090-A1 | Use of Fluorescent Perylene Compounds for the Treatment of Human Hair | SUCLG1, KRT18, POLR1C | FABP3 3963/4885FABP4 3079/4885FABP5 1210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.